Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 20 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 8481552

    Solid forms of gyrase inhibitor (R)-1-ethyl-3-[5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-YL]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-YL]urea

    Vertex Pharmaceuticals Incorporated · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  2. US 8481551

    Gyrase and topoisomerase IV inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  3. US 8481524

    c-MET protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  4. US 8476442

    Process for making modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jul 2, 2013 · Expires Jun 27, 2033

    granted

  5. US 8476281

    Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-yl]urea

    Vertex Pharmaceuticals Incorporated · Granted Jul 2, 2013 · Expires Jun 27, 2033

    granted

  6. US 8471029

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted

  7. US 8471014

    Process of making gyrase and topoisomerase IV inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted

  8. US 8466288

    Isoindolinone inhibitors of phosphatidylinositol 3-kinase

    Vertex Pharmaceuticals Incorporated · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted

  9. US 8461156

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  10. US 8461149

    Compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  11. US 8461345

    Processes for producing phenyl-6-(1-(phenyl)ureido)nicotinamides)

    Vertex Pharmaceuticals Incorporated · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  12. US 8455497

    Inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  13. US 8455507

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  14. US 8450489

    Azaindoles useful as inhibitors of janus kinases

    Vertex Pharmaceuticals Incorporated · Granted May 28, 2013 · Expires May 23, 2033

    granted

  15. US 8445681

    Azaindazoles useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted May 21, 2013 · Expires May 16, 2033

    granted

  16. US 8440706

    Inhibitors of serine proteases

    Vertex Pharmaceuticals Incorporated · Granted May 14, 2013 · Expires May 9, 2033

    granted

  17. US 8436014

    Solid forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted May 7, 2013 · Expires May 2, 2033

    granted

  18. US 8431556

    C-21-keto lupane derivatives preparation and use thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted

  19. US 8431605

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted

  20. US 8431615

    Dose forms

    Vertex Pharmaceuticals Incorporated · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted

  21. US 8426426

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  22. US 8426425

    Aminopyrimidines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  23. US 8426359

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  24. US 8415387

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.